{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:48:28Z","timestamp":1787024908380,"version":"build-2736575974"},"reference-count":58,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Daily and event-driven HIV pre-exposure prophylaxis (PrEP) with oral tenofovir-emtricitabine is highly effective to prevent HIV in men who have sex with men (MSM). PrEP care generally consists of in-clinic monitoring every 3 months that includes PrEP dispensing, counseling, and screening for HIV and sexually transmitted infections (STIs). However, the optimal frequency for monitoring remains undetermined. Attending a clinic every 3 months for monitoring may be a barrier for PrEP. Online-mediated PrEP care and reduced frequency of monitoring may lower this barrier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The primary objective of this study is to establish the noninferiority of online PrEP care (vs in-clinic care) and monitoring every 6 months (vs every 3 months). The secondary objectives are to (1) examine differences between PrEP care modalities regarding incidences of STIs, HIV infection, and hepatitis C virus infection; retention in PrEP care; intracellular tenofovir-diphosphate concentration; and satisfaction, usability, and acceptability of PrEP care modalities; and (2) evaluate associations of these study outcomes with sociodemographic, behavioral, and psychological characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study is a 2\u00d72 factorial, 4-arm, open-label, multi-center, randomized, controlled, noninferiority trial. The 4 arms are (1) in-clinic monitoring every 3 months, (2) in-clinic monitoring every 6 months, (3) online monitoring every 3 months, and (4) online monitoring every 6 months. The primary outcome is a condomless anal sex act with a casual partner not covered or insufficiently covered by PrEP (ie, \u201cunprotected act\u201d) as a proxy for HIV infection risk. Eligible individuals are MSM, and transgender and gender diverse people aged \u226518 years who are eligible for PrEP care at 1 of 4 participating sexual health centers in the Netherlands. The required sample size is 442 participants, and the planned observation time is 24 months. All study participants will receive access to a smartphone app, which contains a diary. Participants are requested to complete the diary on a daily basis during the first 18 months of participation. Participants will complete questionnaires at baseline and 6, 12, 18, and 24 months. Dried blood spots will be collected at 6 and 12 months for assessment of intracellular tenofovir-diphosphate concentration. Incidence rates of unprotected acts will be compared between the online and in-clinic arms, and between the 6-month and 3-month arms. Noninferiority will be concluded if the upper limit of the 2-sided 97.5% CI of the incidence rate ratio is &lt;1.8.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results of the main analysis are expected in 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This trial will demonstrate whether online PrEP care and monitoring every 6 months is noninferior to standard PrEP care in terms of PrEP adherence. If noninferiority is established, these modalities may lower barriers for initiating and continuing PrEP use and potentially reduce the systemic burden for PrEP providers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT05093036; https:\/\/tinyurl.com\/28b8ndvj<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>International Registered Report Identifier (IRRID)<\/jats:title>\n                    <jats:p>DERR1-10.2196\/51023<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/51023","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:18:56Z","timestamp":1695014336000},"page":"e51023","source":"Crossref","is-referenced-by-count":10,"title":["Online-Mediated HIV Pre-exposure Prophylaxis Care and Reduced Monitoring Frequency for Men Who Have Sex With Men: Protocol for a Randomized Controlled Noninferiority Trial (EZI-PrEP Study)"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7365-8657","authenticated-orcid":false,"given":"Marije L","family":"Groot Bruinderink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-8928","authenticated-orcid":false,"given":"Anders","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5830-2982","authenticated-orcid":false,"given":"Liza","family":"Coyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6676-657X","authenticated-orcid":false,"given":"Sophie","family":"Boers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6695-0201","authenticated-orcid":false,"given":"Laura","family":"Blitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7704-4896","authenticated-orcid":false,"given":"Jean-Marie","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-6224","authenticated-orcid":false,"given":"Hannelore M","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0368-482X","authenticated-orcid":false,"given":"Martijn","family":"Stip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0722-8073","authenticated-orcid":false,"given":"Joey","family":"Woudstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9371-5966","authenticated-orcid":false,"given":"Kenneth","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8349-9147","authenticated-orcid":false,"given":"Koenraad","family":"Vermey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4291-1905","authenticated-orcid":false,"given":"Amy","family":"Matser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3294-6242","authenticated-orcid":false,"given":"Allard R","family":"Feddes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-1501","authenticated-orcid":false,"given":"Vita W","family":"Jongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-0289","authenticated-orcid":false,"given":"Maria","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-2109","authenticated-orcid":false,"given":"Elske","family":"Hoornenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3717-2773","authenticated-orcid":false,"given":"Frenk","family":"van Harreveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-7002","authenticated-orcid":false,"given":"Maarten F","family":"Schim van der Loeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-0346","authenticated-orcid":false,"given":"Udi","family":"Davidovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.2591"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00127-2"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001145"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506273"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30089-9"},{"key":"ref8","unstructured":"Differentiated and simplified pre-exposure prophylaxis for HIV prevention: Update to WHO implementation guidance. TECHNICAL BRIEFWorld Health Organization2023-09-30https:\/\/iris.who.int\/bitstream\/handle\/10665\/360861\/9789240053694-eng.pdf"},{"key":"ref9","unstructured":"What\u2019s the 2+1+1? Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: Update to WHO\u2019s recommendation on oral PrEPWorld Health Organisation2023-09-30https:\/\/iris.who.int\/bitstream\/handle\/10665\/325955\/WHO-CDS-HIV-19.8-eng.pdf"},{"key":"ref10","unstructured":"HIV Pre-expositie profylaxe (PrEP) richtlijn NederlandNederlandse Vereniging van Hiv Behandelaren2023-09-30https:\/\/nvhb.nl\/wp-content\/uploads\/2019\/04\/PrEP-richtlijn-Nederland-versie-2-dd-15-april-2019.pdf"},{"key":"ref11","unstructured":"Nederlandse multidisciplinaire richtlijn Pre-expositie profylaxe (PrEP) ter preventie van hivSoa Aids Nederland2023-09-30https:\/\/www.soaaids.nl\/files\/2022-07\/20220711-PrEP-richtlijn-Nederland-versie-3-update-2022.pdf"},{"key":"ref12","unstructured":"WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 13. Integrating STI servicesWorld Health Organization2023-09-30https:\/\/iris.who.int\/bitstream\/handle\/10665\/362227\/9789240057425-eng.pdf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckab177"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-021-03313-w"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/heapro\/daac135"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o1562"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03859-3"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-2667(21)00112-2"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19053002"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01295-0"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02855-9"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25673"},{"key":"ref23","unstructured":"Not PrEPared: Barriers to accessing HIV prevention drugs in EnglandNational AIDS Trust2023-09-30https:\/\/www.nat.org.uk\/sites\/default\/files\/publications\/Not%20PrEPared.pdf"},{"key":"ref24","unstructured":"Verzoek om reactie op petitie Aidsfonds en meerdere organisaties m.b.t. PrEPOverheid2023-09-30https:\/\/open.overheid.nl\/documenten\/ronl-a29cfa1428fd78e4b46c7500b80e91c7cb2412a1\/pdf"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3018(22)00030-3"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-05568-w"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-019-00430-z"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2196\/37479"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-022-00630-0"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001017"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2196\/13982"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3521-2"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001873"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-020-00528-9"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003143"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30271-X"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00126-6"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00175-X"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1177\/0956462420957519"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1177\/09564624211025940"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2021-055298"},{"key":"ref42","unstructured":"van SighemAIWitFWNMBoydASmitCMatserAvan der ValkMHuman Immunodeficiency Virus (HIV) Infection in the NetherlandsHIV Monitoring Report 2022Amsterdamhttps:\/\/www.hiv-monitoring.nl\/application\/files\/1816\/6851\/5357\/NL_HIV_MONITORING_REPORT_2022.pdf"},{"key":"ref43","unstructured":"Adherence to long-term therapies : evidence for actionWorld Health Organization2023-09-30https:\/\/iris.who.int\/handle\/10665\/42682"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.12.013"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S19801"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1177\/1359105318755545"},{"key":"ref47","unstructured":"PrEPRijksinstituut voor Volksgezondheid en Milieu2023-09-30https:\/\/www.rivm.nl\/soa\/prep"},{"key":"ref48","unstructured":"EZI-PrEP2023-09-30https:\/\/www.eziprep.nl\/"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31816fcb0a"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25708"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1089\/AID.2012.0089"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2307\/249008"},{"key":"ref53","author":"Brooke, J","year":"1996","journal-title":"Usability Evaluation In Industry"},{"key":"ref54","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-1586-3","author":"Friedman, LM","year":"2010","journal-title":"Fundamentals of Clinical Trials"},{"key":"ref55","unstructured":"van WeesDAVisserMvan AarFOp de CoulELMStaritskyLESarinkDWillemsteinIJMde VriesAKustersJMAden BoogertEAlexiouZWG\u00f6tzHMJansenTvan SighemAIHeijneJCMSexually transmitted infections in the Netherlands in 20212022National Institute for Public Health and the Environmenthttps:\/\/rivm.openrepository.com\/handle\/10029\/625860"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.201200142"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30215-7"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002790"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2023\/1\/e51023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:34:28Z","timestamp":1782840868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2023\/1\/e51023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":58,"URL":"https:\/\/doi.org\/10.2196\/51023","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.51023","asserted-by":"object"}]},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]}}}